Vanda Pharmaceuticals
VNDA
#8376
Rank
ยฃ0.23 B
Marketcap
ยฃ3.91
Share price
-2.76%
Change (1 day)
12.26%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -ยฃ0.12 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2025 the company made an earning of -ยฃ0.12 Billion a decrease over its 2024 earnings that were of -ยฃ30.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.12 Billion6.75%
2025 -ยฃ0.12 Billion271.79%
2024 -ยฃ30.04 Million191.43%
2023 -ยฃ10.31 Million-320.45%
2022 ยฃ4.67 M-84.99%
2021 ยฃ31.14 M54.8%
2020 ยฃ20.12 M19.42%
2019 ยฃ16.84 M4.93%
2018 ยฃ16.05 M-228.6%
2017 -ยฃ12.49 Million-8.98%
2016 -ยฃ13.72 Million-53.79%
2015 -ยฃ29.69 Million-30.18%
2014 -ยฃ42.52 Million173.08%
2013 -ยฃ15.57 Million-25.33%
2012 -ยฃ20.85 Million163.61%
2011 -ยฃ7.91 Million-221.15%
2010 ยฃ6.52 M-124.53%
2009 -ยฃ26.62 Million-29.44%
2008 -ยฃ37.73 Million-36.2%
2007 -ยฃ59.13 Million21.81%
2006 -ยฃ48.54 Million170.55%
2005 -ยฃ17.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.19 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.65 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ7.82 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ22.99 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.71 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.08 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.08 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA